Livija Šimičević

Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

Pharmacogenomics

Genes

Journal of clinical pharmacy and therapeutics

European journal of clinical pharmacology

KBC Zagreb Klinicki zavod za laboratorijsku dijagnostiku

Medicinski Fakultet, Sveučilište u Zagrebu (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

KBC Zagreb Klinicki zavod za laboratorijsku dijagnostiku

Croatia

Spec.med.biokem i lab.med. :: Odjel za farmakogenomiku i individualizaciju terapije

Sanofi-Aventis France SA

Croatia

Medical Adviser

Pliva (Croatia)

Croatia

Therapeutic Area Manager / Sumamed & PLIVA antiinfectives :: Medical and Marketing Affairs (CEE Region)

Novo Nordisk

Croatia

CRA :: Medical

Pliva (Croatia)

Croatia

Clinical Trial Specialist :: Medical and Marketing Affairs (CEE Region)

Education History

Medicinski Fakultet, Sveučilište u Zagrebu

Croatia

PHD :: PhD Programme Biomedicine and Health Sciences

Sveuciliste u Zagrebu Farmaceutsko-biokemijski fakultet

Croatia

MSC

Publications

Lana Ganoci, Jozefina Palić, Vladimir Trkulja, Katarina Starčević, Livija Šimičević, Nada Božina, Martina Lovrić-Benčić, Zdravka Poljaković, Tamara Božina
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients? Genes 15 (5) (2024)
Lana Ganoci, Jozefina Palić, Vladimir Trkulja, Katarina Starčević, Livija Šimičević, Nada Božina, Martina Lovrić-Benčić, Zdravka Poljaković, Tamara Božina
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients? Genes 15 (5) (2024)
Lana Ganoci, Jozefina Palić, Vladimir Trkulja, Katarina Starčević, Livija Šimičević, Nada Božina, Martina Lovrić-Benčić, Zdravka Poljaković, Tamara Božina
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients? Genes 15 (5) (2024)
Lana Ganoci, Jozefina Palić, Vladimir Trkulja, Katarina Starčević, Livija Šimičević, Nada Božina, Martina Lovrić-Benčić, Zdravka Poljaković, Tamara Božina
Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients? Genes 15 (5) (2024)
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? Pharmacogenomics (2023)
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? Pharmacogenomics 24 (2) (2023)
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? Pharmacogenomics (2023)
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? Pharmacogenomics 24 (2) (2023)
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? Pharmacogenomics 24 (2) (2023)
Lucija Lešnjaković, Lana Ganoci, Ivan Bilić, Livija Šimičević, Iva Mucalo, Stjepko Pleština, Nada Božina
DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? Pharmacogenomics 24 (2) (2023)
Livija Šimičević, Iva Canjuga, Lada Zibar, Ana Borić-Bilušić, Lana Ganoci, Nada Božina
Rapid clearance of tacrolimus blood concentration triggered by variant pharmacogenes. Journal of clinical pharmacy and therapeutics 47 (9) (2022)
Iveta Merćep, Ivana Radman, Vladimir Trkulja, Tamara Božina, Livija Šimičević, Ema Budimir, Lana Ganoci, Nada Božina
Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study. European journal of clinical pharmacology (2021)
Darija Kuruc Poje, Nada Božina, Livija Šimičević, Igor Žabić
Severe hyperglycaemia following pazopanib treatment: The role of drug-drug-gene interactions in a patient with metastatic renal cell carcinoma-A case report. Journal of clinical pharmacy and therapeutics 45 (4) (2020)

Livija Šimičević.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Livija Šimičević